How a claim degrades between the bench and the listing
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 50 of 68 of this archive, newest first.
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
Micronutrient guidance for this drug class is borrowed almost entirely from post-bariatric surveillance, where the anatomy is different and the deficiency mechanisms are not…
Chain of custody, in a regulated setting, begins at sampling. Here it begins when the package arrives.
Reported from the analysis, not from a warning notice.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
An orthogonal method separates on a different physical principle, so that species co-eluting in the first are likely to resolve in the second. Two runs of the same method at…
Reported from the analysis, not from a warning notice.
Reported from the sessions, and from the two hours afterwards.
The evidence base is thin and the document says so, which is to its credit.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Receptor pharmacology is strong on average effects and almost silent on individual variation. That gap is where most reader questions live.
The sequence predicts the failure mode. A methionine predicts oxidation; an asparagine followed by a glycine predicts deamidation; a cysteine predicts disulphide scrambling.
Dose reduction is not withdrawal, and the trials that tested withdrawal cannot be read as testing it.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The route did not close because of a rule about peptides.
The observation that closes a facility is rarely the dramatic one.
Follow the resin, not the catalogue.
Repeated injection into the same small area produces lipohypertrophy — thickened, rubbery subcutaneous tissue with blunted and erratic absorption. It is common, it is…
Concentrations fall by half a week, so a month away leaves a small fraction of steady state. Resuming at the previous dose presents the receptor with a step it has not seen…
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The route did not close because of a rule about peptides.
A proper account of an operation that existed, and of what closing it cost.
The result is unremarkable. What the report states alongside it is not.
Dye ingress and microbial immersion are probabilistic. Vacuum decay, high-voltage leak detection and helium mass spectrometry are deterministic and far more sensitive.
The route did not close because of a rule about peptides.
The evidence base is thin and the document says so, which is to its credit.
The observation that closes a facility is rarely the dramatic one.
A reminder that a purity figure is the output of a method, and that methods differ.
A peptide has a monoisotopic mass and an average mass, they differ by several daltons at this molecular size, and a certificate that does not say which it quotes cannot be…